{"id":47371,"date":"2022-08-17T11:01:55","date_gmt":"2022-08-17T09:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/"},"modified":"2022-08-17T11:01:55","modified_gmt":"2022-08-17T09:01:55","slug":"regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/","title":{"rendered":"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/3162392\/global-regenerative-medicine-partnering-terms-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=d6s2gf&amp;utm_campaign=1738894+-+Regenerative+Medicine+Partnering+2015+to+2022%3A+Terms+and+Agreements+Entered+Into+by+the+Leading+Companies+Worldwide&amp;utm_exec=joca220prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Regenerative Medicine Partnering Terms and Agreements 2015 to 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide.\n<\/p>\n<p>\n<strong>Regenerative Medicine Partnering Terms and Agreements includes:<\/strong>\n<\/p>\n<ul>\n<li>\nTrends in Regenerative Medicine dealmaking in the biopharma industry since 2015\n<\/li>\n<li>\nAccess to headline, upfront, milestone and royalty data\n<\/li>\n<li>\nAccess to Regenerative Medicine contract documents\n<\/li>\n<li>\nLeading Regenerative Medicine deals by value since 2015\n<\/li>\n<li>\nMost active Regenerative Medicine dealmakers since 2015\n<\/li>\n<\/ul>\n<p>\n<strong>In Global Regenerative Medicine Partnering Terms and Agreements 2015-2022, the available deals are listed by:<\/strong>\n<\/p>\n<ul>\n<li>\nCompany A-Z\n<\/li>\n<li>\nHeadline value\n<\/li>\n<li>\nStage of development at signing\n<\/li>\n<li>\nDeal component type\n<\/li>\n<li>\nSpecific therapy target\n<\/li>\n<li>\nTechnology type\n<\/li>\n<\/ul>\n<p>\nEach deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.\n<\/p>\n<p>\nThe Global Regenerative Medicine Partnering terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 1600 Regenerative Medicine deals.\n<\/p>\n<p>\n<strong>Analyzing actual contract agreements allows assessment of the following:<\/strong>\n<\/p>\n<ul>\n<li>\nWhat are the precise rights granted or optioned?\n<\/li>\n<li>\nWhat is actually granted by the agreement to the partner company?\n<\/li>\n<li>\nWhat exclusivity is granted?\n<\/li>\n<li>\nWhat is the payment structure for the deal?\n<\/li>\n<li>\nHow are sales and payments audited?\n<\/li>\n<li>\nWhat is the deal term?\n<\/li>\n<li>\nHow are the key terms of the agreement defined?\n<\/li>\n<li>\nHow are IPRs handled and owned?\n<\/li>\n<li>\nWho is responsible for commercialization?\n<\/li>\n<li>\nWho is responsible for development, supply, and manufacture?\n<\/li>\n<li>\nHow is confidentiality and publication managed?\n<\/li>\n<li>\nHow are disputes to be resolved?\n<\/li>\n<li>\nUnder what conditions can the deal be terminated?\n<\/li>\n<li>\nWhat happens when there is a change of ownership?\n<\/li>\n<li>\nWhat sublicensing and subcontracting provisions have been agreed?\n<\/li>\n<li>\nWhich boilerplate clauses does the company insist upon?\n<\/li>\n<li>\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?\n<\/li>\n<li>\nWhich jurisdiction does the company insist upon for agreement law?\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\n2seventy bio\n<\/li>\n<li>\n3D-Side\n<\/li>\n<li>\n3D Medicines\n<\/li>\n<li>\n3D Systems\n<\/li>\n<li>\n3SBio\n<\/li>\n<li>\n4basebio Discovery\n<\/li>\n<li>\n4D Molecular Therapeutics\n<\/li>\n<li>\n180 Life Sciences\n<\/li>\n<li>\nA*STAR Agency for Science\n<\/li>\n<li>\nTechnology and Research\n<\/li>\n<li>\nA*STAR Genome Institute of Singapore\n<\/li>\n<li>\nA*STAR&#8217; Institute of Molecular and Cell Biology\n<\/li>\n<li>\nA2 Biotherapeutics\n<\/li>\n<li>\nAavantiBio\n<\/li>\n<li>\nAAVnerGene\n<\/li>\n<li>\nAbbvie\n<\/li>\n<li>\nAbby Grace Foundation\n<\/li>\n<li>\nAbcam\n<\/li>\n<li>\nAbCellera\n<\/li>\n<li>\nAbeona Therapeutics\n<\/li>\n<li>\nAbingworth Management\n<\/li>\n<li>\nAbintus Bio\n<\/li>\n<li>\nAblynx\n<\/li>\n<li>\nAbound Bio\n<\/li>\n<li>\nAbu Dhabi Stem Cells Center\n<\/li>\n<li>\nAbveris\n<\/li>\n<li>\nAbzena\n<\/li>\n<li>\nAccelerated Biosciences\n<\/li>\n<li>\nAccelerator for Technological Research in Genomic Therapies\n<\/li>\n<li>\nAccellix\n<\/li>\n<li>\nAccellta\n<\/li>\n<li>\nAccenture\n<\/li>\n<li>\nAccuResearch\n<\/li>\n<li>\nACEA Biosciences\n<\/li>\n<li>\nAcepodia\n<\/li>\n<li>\nAceso Life Science\n<\/li>\n<li>\nand many, many more!\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/3162392\/global-regenerative-medicine-partnering-terms-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=d6s2gf&amp;utm_campaign=1738894+-+Regenerative+Medicine+Partnering+2015+to+2022%3A+Terms+and+Agreements+Entered+Into+by+the+Leading+Companies+Worldwide&amp;utm_exec=joca220prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/pu1ymr<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#112;&#114;&#101;&#115;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;hand&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#115;&#115;&#64;r&#x65;&#x73;&#x65;&#97;&#114;ch&#x61;&#x6e;&#x64;&#109;&#97;rk&#x65;&#x74;&#x73;&#46;&#99;om<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Regenerative Medicine Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide. Regenerative Medicine Partnering Terms and Agreements includes: Trends &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47371","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Regenerative Medicine Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide. Regenerative Medicine Partnering Terms and Agreements includes: Trends ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-17T09:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-17T09:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/\"},\"wordCount\":486,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005309\\\/en\\\/1546624\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/\",\"name\":\"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005309\\\/en\\\/1546624\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-17T09:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005309\\\/en\\\/1546624\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220817005309\\\/en\\\/1546624\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Regenerative Medicine Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide. Regenerative Medicine Partnering Terms and Agreements includes: Trends ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-17T09:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide &#8211; ResearchAndMarkets.com","datePublished":"2022-08-17T09:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/"},"wordCount":486,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/","name":"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/21\/logo.jpg","datePublished":"2022-08-17T09:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220817005309\/en\/1546624\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/regenerative-medicine-partnering-2015-to-2022-terms-and-agreements-entered-into-by-the-leading-companies-worldwide-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Regenerative Medicine Partnering 2015 to 2022: Terms and Agreements Entered Into by the Leading Companies Worldwide &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47371"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47371\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}